{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T13:08:54Z","timestamp":1793711334109,"version":"4.6.1"},"reference-count":133,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Neurol"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1038\/s41582-021-00467-y","type":"journal-article","created":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T18:03:55Z","timestamp":1614621835000},"page":"285-296","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":98,"title":["Guillain\u2013Barr\u00e9 syndrome in low-income and middle-income countries: challenges and prospects"],"prefix":"10.1038","volume":"17","author":[{"given":"Nowshin","family":"Papri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0935-8079","authenticated-orcid":false,"given":"Zhahirul","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4832-6926","authenticated-orcid":false,"given":"Sonja E.","family":"Leonhard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quazi D.","family":"Mohammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubert P.","family":"Endtz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8985-2458","authenticated-orcid":false,"given":"Bart C.","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,1]]},"reference":[{"key":"467_CR1","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1093\/brain\/awt285","volume":"137","author":"C Fokke","year":"2014","unstructured":"Fokke, C. et al. Diagnosis of Guillain\u2013Barr\u00e9 syndrome and validation of Brighton criteria. Brain 137, 33\u201343 (2014).","journal-title":"Brain"},{"key":"467_CR2","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nrneurol.2014.121","volume":"10","author":"B Van Den Berg","year":"2014","unstructured":"Van Den Berg, B. et al. Guillain\u2013Barr\u00e9 syndrome: pathogenesis, diagnosis, treatment and prognosis. Nat. Rev. Neurol. 10, 469 (2014).","journal-title":"Nat. Rev. Neurol."},{"key":"467_CR3","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S1474-4422(08)70215-1","volume":"7","author":"PA Van Doorn","year":"2008","unstructured":"Van Doorn, P. A., Ruts, L. & Jacobs, B. C. Clinical features, pathogenesis, and treatment of Guillain\u2013Barr\u00e9 syndrome. Lancet Neurol. 7, 939\u2013950 (2008).","journal-title":"Lancet Neurol."},{"key":"467_CR4","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1056\/NEJMoa1605564","volume":"375","author":"B Parra","year":"2016","unstructured":"Parra, B. et al. Guillain\u2013Barr\u00e9 syndrome associated with Zika virus infection in Colombia. N. Engl. J. Med. 375, 1513\u20131523 (2016).","journal-title":"N. Engl. J. Med."},{"key":"467_CR5","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1111\/jns.12358","volume":"24","author":"SE Leonhard","year":"2019","unstructured":"Leonhard, S. E., Conde, R. M., de Assis Aquino Gondim, F. & Jacobs, B. C. Diagnosis and treatment of Guillain\u2013Barr\u00e9 syndrome during the Zika virus epidemic in Brazil: a national survey study. J. Peripher. Nerv. Syst. 24, 340\u2013347 (2019).","journal-title":"J. Peripher. Nerv. Syst."},{"key":"467_CR6","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/S0140-6736(16)00562-6","volume":"387","author":"V-M Cao-Lormeau","year":"2016","unstructured":"Cao-Lormeau, V.-M. et al. Guillain\u2013Barr\u00e9 syndrome outbreak associated with Zika virus infection in French Polynesia: a case\u2013control study. Lancet 387, 1531\u20131539 (2016).","journal-title":"Lancet"},{"key":"467_CR7","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.ncl.2013.01.005","volume":"31","author":"MM Dimachkie","year":"2013","unstructured":"Dimachkie, M. M. & Barohn, R. J. Guillain\u2013Barr\u00e9 syndrome and variants. Neurol. Clin. 31, 491\u2013510 (2013).","journal-title":"Neurol. Clin."},{"key":"467_CR8","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1007\/s00415-016-8192-2","volume":"263","author":"T Hosokawa","year":"2016","unstructured":"Hosokawa, T. et al. Serial electrophysiological findings in Guillain\u2013Barr\u00e9 syndrome not fulfilling AIDP or AMAN criteria. J. Neurol. 263, 1709\u20131718 (2016).","journal-title":"J. Neurol."},{"key":"467_CR9","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1056\/NEJMra1114525","volume":"366","author":"N Yuki","year":"2012","unstructured":"Yuki, N. & Hartung, H.-P. Guillain\u2013Barr\u00e9 syndrome. N. Engl. J. Med. 366, 2294\u20132304 (2012).","journal-title":"N. Engl. J. Med."},{"key":"467_CR10","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/S0140-6736(16)00339-1","volume":"388","author":"HJ Willison","year":"2016","unstructured":"Willison, H. J., Jacobs, B. C. & Van Doorn, P. A. Guillain\u2013Barr\u00e9 syndrome. Lancet 388, 717\u2013727 (2016).","journal-title":"Lancet"},{"key":"467_CR11","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1093\/brain\/awm004","volume":"130","author":"RA Hughes","year":"2007","unstructured":"Hughes, R. A. et al. Immunotherapy for Guillain\u2013Barr\u00e9 syndrome: a systematic review. Brain 130, 2245\u20132257 (2007).","journal-title":"Brain"},{"key":"467_CR12","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.1093\/brain\/awy232","volume":"141","author":"AY Doets","year":"2018","unstructured":"Doets, A. Y. et al. Regional variation of Guillain\u2013Barr\u00e9 syndrome. Brain 141, 2866\u20132877 (2018).","journal-title":"Brain"},{"key":"467_CR13","unstructured":"The World Bank. Data: World Bank Country and Lending Groups. The World Bank http:\/\/databank.worldbank.org\/data\/download\/site-content\/OGHIST.xls (2019)."},{"key":"467_CR14","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1212\/WNL.0b013e3181cff735","volume":"74","author":"Z Islam","year":"2010","unstructured":"Islam, Z. et al. Axonal variant of Guillain\u2013Barr\u00e9 syndrome associated with Campylobacter infection in Bangladesh. Neurology 74, 581\u2013587 (2010).","journal-title":"Neurology"},{"key":"467_CR15","first-page":"1000138","volume":"7","author":"M Pal","year":"2018","unstructured":"Pal, M., Ayele, Y., Hadush, M., Panigrahi, S. & Jadhav, V. J. Public health hazards due to unsafe drinking water. Air Water Borne Dis. 7, 1000138 (2018).","journal-title":"Air Water Borne Dis."},{"key":"467_CR16","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1089\/fpd.2009.0493","volume":"7","author":"M Zhang","year":"2010","unstructured":"Zhang, M. et al. Association study between an outbreak of Guillain\u2013Barr\u00e9 syndrome in Jilin, China, and preceding Campylobacter jejuni infection. Foodborne Pathog. Dis. 7, 913\u2013919 (2010).","journal-title":"Foodborne Pathog. Dis."},{"key":"467_CR17","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1017\/S0950268813001908","volume":"142","author":"B Jackson","year":"2014","unstructured":"Jackson, B. et al. Binational outbreak of Guillain\u2013Barr\u00e9 syndrome associated with Campylobacter jejuni infection, Mexico and USA, 2011. Epidemiol. Infect. 142, 1089\u20131099 (2014).","journal-title":"Epidemiol. Infect."},{"key":"467_CR18","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-022862","volume":"8","author":"B Islam","year":"2018","unstructured":"Islam, B. et al. Small volume plasma exchange for Guillain\u2013Barr\u00e9 syndrome in resource-limited settings: a phase II safety and feasibility study. BMJ Open 8, e022862 (2018).","journal-title":"BMJ Open"},{"key":"467_CR19","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1007\/s00415-017-8429-8","volume":"264","author":"J Roodbol","year":"2017","unstructured":"Roodbol, J. et al. Diagnosis of Guillain\u2013Barr\u00e9 syndrome in children and validation of the Brighton criteria. J. Neurol. 264, 856\u2013861 (2017).","journal-title":"J. Neurol."},{"key":"467_CR20","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1159\/000052111","volume":"45","author":"F Van der Mech\u00e9","year":"2001","unstructured":"Van der Mech\u00e9, F., Van Doorn, P., Meulstee, J. & Jennekens, F. Diagnostic and classification criteria for the Guillain\u2013Barr\u00e9 syndrome. Eur. Neurol. 45, 133\u2013139 (2001).","journal-title":"Eur. Neurol."},{"key":"467_CR21","doi-asserted-by":"publisher","first-page":"e59","DOI":"10.1212\/WNL.0000000000007719","volume":"93","author":"C Verboon","year":"2019","unstructured":"Verboon, C. et al. Current treatment practice of Guillain\u2013Barr\u00e9 syndrome. Neurology 93, e59\u2013e76 (2019).","journal-title":"Neurology"},{"key":"467_CR22","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/jns.12215","volume":"22","author":"T Ishaque","year":"2017","unstructured":"Ishaque, T. et al. High mortality from Guillain\u2013Barr\u00e9 syndrome in Bangladesh. J. Peripher. Nerv. Syst. 22, 121\u2013126 (2017).","journal-title":"J. Peripher. Nerv. Syst."},{"key":"467_CR23","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jocn.2017.08.048","volume":"46","author":"M Nagappa","year":"2017","unstructured":"Nagappa, M. et al. Guillain\u2013Barr\u00e9 syndrome in the elderly: experience from a tertiary-care hospital in India. J. Clin. Neurosci. 46, 45\u201349 (2017).","journal-title":"J. Clin. Neurosci."},{"key":"467_CR24","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1159\/000324710","volume":"36","author":"JJ Sejvar","year":"2011","unstructured":"Sejvar, J. J., Baughman, A. L., Wise, M. & Morgan, O. W. Population incidence of Guillain\u2013Barr\u00e9 syndrome: a systematic review and meta-analysis. Neuroepidemiology 36, 123\u2013133 (2011).","journal-title":"Neuroepidemiology"},{"key":"467_CR25","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1159\/000184748","volume":"32","author":"A McGrogan","year":"2009","unstructured":"McGrogan, A., Madle, G. C., Seaman, H. E. & De Vries, C. S. The epidemiology of Guillain\u2013Barr\u00e9 syndrome worldwide. Neuroepidemiology 32, 150\u2013163 (2009).","journal-title":"Neuroepidemiology"},{"key":"467_CR26","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.3201\/eid1707.101999","volume":"17","author":"Z Islam","year":"2011","unstructured":"Islam, Z. et al. High incidence of Guillain\u2013Barr\u00e9 syndrome in children, Bangladesh. Emerg. Infect. Dis. 17, 1317\u20131318 (2011).","journal-title":"Emerg. Infect. Dis."},{"key":"467_CR27","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1016\/S0140-6736(05)67665-9","volume":"366","author":"RA Hughes","year":"2005","unstructured":"Hughes, R. A. & Cornblath, D. R. Guillain\u2013Barr\u00e9 syndrome. Lancet 366, 1653\u20131666 (2005).","journal-title":"Lancet"},{"key":"467_CR28","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1212\/WNL.56.11.1467","volume":"56","author":"R Van Koningsveld","year":"2001","unstructured":"Van Koningsveld, R. et al. Gastroenteritis-associated Guillain\u2013Barr\u00e9 syndrome on the Caribbean island Curacao. Neurology 56, 1467\u20131472 (2001).","journal-title":"Neurology"},{"key":"467_CR29","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1136\/jnnp-2014-309056","volume":"86","author":"AJ Webb","year":"2015","unstructured":"Webb, A. J., Brain, S. A., Wood, R., Rinaldi, S. & Turner, M. R. Seasonal variation in Guillain\u2013Barr\u00e9 syndrome: a systematic review, meta-analysis and Oxfordshire cohort study. J. Neurol. Neurosurg. Psychiatry 86, 1196\u20131201 (2015).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"467_CR30","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1586\/1744666X.2013.811119","volume":"9","author":"BR Wakerley","year":"2013","unstructured":"Wakerley, B. R. & Yuki, N. Infectious and noninfectious triggers in Guillain\u2013Barr\u00e9 syndrome. Expert Rev. Clin. Immunol. 9, 627\u2013639 (2013).","journal-title":"Expert Rev. Clin. Immunol."},{"key":"467_CR31","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1093\/cid\/ciu005","volume":"58","author":"C Vellozzi","year":"2014","unstructured":"Vellozzi, C., Iqbal, S. & Broder, K. Guillain\u2013Barr\u00e9 syndrome, influenza, and influenza vaccination: the epidemiologic evidence. Clin. Infect. Dis. 58, 1149\u20131155 (2014).","journal-title":"Clin. Infect. Dis."},{"key":"467_CR32","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1093\/brain\/118.3.597","volume":"118","author":"T Ho","year":"1995","unstructured":"Ho, T. et al. Guillain\u2013Barr\u00e9 syndrome in northern China: relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain 118, 597\u2013605 (1995).","journal-title":"Brain"},{"key":"467_CR33","doi-asserted-by":"publisher","first-page":"e564","DOI":"10.1016\/S2214-109X(15)00151-5","volume":"3","author":"JA Platts-Mills","year":"2015","unstructured":"Platts-Mills, J. A. et al. Pathogen-specific burdens of community diarrhoea in developing countries: a multisite birth cohort study (MAL-ED). Lancet Glob. Health 3, e564\u2013e575 (2015).","journal-title":"Lancet Glob. Health"},{"key":"467_CR34","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1097\/MPG.0b013e3181df5b66","volume":"51","author":"A Larrosa-Haro","year":"2010","unstructured":"Larrosa-Haro, A., Macias-Rosales, R., S\u00e1nchez-Ram\u00edrez, C. A., Cort\u00e9s-L\u00f3pez, M. C. & Aguilar-Benavides, S. Seasonal variation of enteropathogens in infants and preschoolers with acute diarrhea in western Mexico. J. Pediatr. Gastroenterol. Nutr. 51, 534\u2013536 (2010).","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"467_CR35","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1007\/BF00314485","volume":"235","author":"M Bahemuka","year":"1988","unstructured":"Bahemuka, M. Guillain\u2013Barr\u00e9 syndrome in Kenya: a clinical review of 54 patients. J. Neurol. 235, 418\u2013421 (1988).","journal-title":"J. Neurol."},{"key":"467_CR36","doi-asserted-by":"publisher","first-page":"35","DOI":"10.11604\/pamj.2014.18.35.2911","volume":"18","author":"B Charra","year":"2014","unstructured":"Charra, B., Hachimi, A., Benslama, A. & Motaouakkil, S. Intravenous immunoglobulin vs. plasma exchange in treatment of mechanically ventilated adults with Guillain\u2013Barr\u00e9 syndrome. Pan Afr. Med. J. 18, 35 (2014).","journal-title":"Pan Afr. Med. J."},{"key":"467_CR37","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1046\/j.1468-1331.2003.00683.x","volume":"10","author":"BC Cheng","year":"2003","unstructured":"Cheng, B. C. et al. Guillain\u2013Barr\u00e9 syndrome in southern Taiwan: clinical features, prognostic factors and therapeutic outcomes. Eur. J. Neurol. 10, 655\u2013662 (2003).","journal-title":"Eur. J. Neurol."},{"key":"467_CR38","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/j.1600-0404.1996.tb00169.x","volume":"93","author":"W Howlett","year":"1996","unstructured":"Howlett, W., Vedeler, C., Nyland, H. & Aarli, J. Guillain\u2013Barr\u00e9 syndrome in northern Tanzania: a comparison of epidemiological and clinical findings with western Norway. Acta Neurol. Scand. 93, 44\u201349 (1996).","journal-title":"Acta Neurol. Scand."},{"key":"467_CR39","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.jns.2016.08.014","volume":"369","author":"L-S Liou","year":"2016","unstructured":"Liou, L.-S. et al. Epidemiology and prognostic factors of inpatient mortality of Guillain\u2013Barr\u00e9 syndrome: a nationwide population study over 14 years in Asian country. J. Neurol. Sci. 369, 159\u2013164 (2016).","journal-title":"J. Neurol. Sci."},{"key":"467_CR40","first-page":"21","volume":"43","author":"Z Melaku","year":"2005","unstructured":"Melaku, Z., Zenebe, G. & Bekele, A. Guillain\u2013Barr\u00e9 syndrome in Ethiopian patients. Ethiopian Med. J. 43, 21\u201326 (2005).","journal-title":"Ethiopian Med. J."},{"key":"467_CR41","doi-asserted-by":"publisher","first-page":"262","DOI":"10.4103\/0972-2327.91942","volume":"14","author":"AB Netto","year":"2011","unstructured":"Netto, A. B., Taly, A. B., Kulkarni, G. B., Rao, U. G. & Rao, S. Mortality in mechanically ventilated patients of Guillain\u2013Barr\u00e9 syndrome. Ann. Indian Acad. Neurol. 14, 262\u2013266 (2011).","journal-title":"Ann. Indian Acad. Neurol."},{"key":"467_CR42","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.jocn.2018.11.031","volume":"62","author":"SH Siddiqui","year":"2019","unstructured":"Siddiqui, S. H., Siddiqui, T. H., Babar, M. U., Khoja, A. & Khan, S. Outcomes of patients with Guillain\u2013Barr\u00e9 syndrome \u2014 experience from a tertiary care hospital of a developing Asian country and review of regional literature. J. Clin. Neurosci. 62, 195\u2013198 (2019).","journal-title":"J. Clin. Neurosci."},{"key":"467_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0003674","volume":"3","author":"TF Wierzba","year":"2008","unstructured":"Wierzba, T. F. et al. Campylobacter infection as a trigger for Guillain\u2013Barr\u00e9 syndrome in Egypt. PLoS ONE 3, e3674 (2008).","journal-title":"PLoS ONE"},{"key":"467_CR44","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/j.1600-0404.2011.01503.x","volume":"125","author":"M Dourado","year":"2012","unstructured":"Dourado, M., Felix, R., da Silva, W., Queiroz, J. & Jeronimo, S. Clinical characteristics of Guillain\u2013Barr\u00e9 syndrome in a tropical country: a Brazilian experience. Acta Neurol. Scand. 125, 47\u201353 (2012).","journal-title":"Acta Neurol. Scand."},{"key":"467_CR45","doi-asserted-by":"publisher","first-page":"S73","DOI":"10.4103\/0972-2327.83087","volume":"14","author":"A Meena","year":"2011","unstructured":"Meena, A., Khadilkar, S. & Murthy, J. Treatment guidelines for Guillain\u2013Barr\u00e9 syndrome. Ann. Indian Acad. Neurol. 14, S73\u2013S81 (2011).","journal-title":"Ann. Indian Acad. Neurol."},{"key":"467_CR46","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1128\/CMR.00006-15","volume":"28","author":"NO Kaakoush","year":"2015","unstructured":"Kaakoush, N. O., Casta\u00f1o-Rodr\u00edguez, N., Mitchell, H. M. & Man, S. M. Global epidemiology of Campylobacter infection. Clin. Microbiol. Rev. 28, 687\u2013720 (2015).","journal-title":"Clin. Microbiol. Rev."},{"key":"467_CR47","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/S1474-4422(07)70130-8","volume":"6","author":"R van Koningsveld","year":"2007","unstructured":"van Koningsveld, R. et al. A clinical prognostic scoring system for Guillain\u2013Barr\u00e9 syndrome. Lancet Neurol. 6, 589\u2013594 (2007).","journal-title":"Lancet Neurol."},{"key":"467_CR48","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1136\/jnnp-2013-306212","volume":"85","author":"JS Bae","year":"2014","unstructured":"Bae, J. S. et al. Guillain\u2013Barr\u00e9 syndrome in Asia. J. Neurol. Neurosurg. Psychiatry 85, 907\u2013913 (2014).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"467_CR49","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1136\/jnnp-2013-306509","volume":"86","author":"Y Mitsui","year":"2015","unstructured":"Mitsui, Y. et al. A multicentre prospective study of Guillain\u2013Barr\u00e9 syndrome in Japan: a focus on the incidence of subtypes. J. Neurol. Neurosurg. Psychiatry 86, 110\u2013114 (2015).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"467_CR50","doi-asserted-by":"crossref","first-page":"314","DOI":"10.47102\/annals-acadmedsg.V33N3p314","volume":"33","author":"Y Ng","year":"2004","unstructured":"Ng, Y., Lo, Y. & Lim, P. Characteristics and acute rehabilitation of Guillain\u2013Barr\u00e9 syndrome in Singapore. Ann. Acad. Med. Singap. 33, 314\u2013319 (2004).","journal-title":"Ann. Acad. Med. Singap."},{"key":"467_CR51","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1212\/WNL.57.4.686","volume":"57","author":"M Koga","year":"2001","unstructured":"Koga, M., Yuki, N., Tai, T. & Hirata, K. Miller Fisher syndrome and Haemophilus influenzae infection. Neurology 57, 686\u2013691 (2001).","journal-title":"Neurology"},{"key":"467_CR52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0133520","volume":"10","author":"G Zhang","year":"2015","unstructured":"Zhang, G. et al. Subtypes and prognosis of Guillain\u2013Barr\u00e9 syndrome in southwest China. PLoS ONE 10, e0133520 (2015).","journal-title":"PLoS ONE"},{"key":"467_CR53","doi-asserted-by":"publisher","first-page":"5544","DOI":"10.1016\/j.vaccine.2018.05.119","volume":"37","author":"N Principi","year":"2019","unstructured":"Principi, N. & Esposito, S. Vaccine-preventable diseases, vaccines and Guillain\u2013Barr\u00e9 syndrome. Vaccine 37, 5544\u20135550 (2019).","journal-title":"Vaccine"},{"key":"467_CR54","doi-asserted-by":"publisher","first-page":"e1220","DOI":"10.1212\/WNL.0000000000006246","volume":"91","author":"J Rudant","year":"2018","unstructured":"Rudant, J. et al. Surgery and risk of Guillain\u2013Barr\u00e9 syndrome: a French nationwide epidemiologic study. Neurology 91, e1220\u2013e1227 (2018).","journal-title":"Neurology"},{"key":"467_CR55","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.jns.2017.02.024","volume":"375","author":"FL Hiew","year":"2017","unstructured":"Hiew, F. L. & Rajabally, Y. A. Malignancy in Guillain\u2013Barr\u00e9 syndrome: a twelve-year single-center study. J. Neurol. Sci. 375, 275\u2013278 (2017).","journal-title":"J. Neurol. Sci."},{"key":"467_CR56","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1111\/j.1468-1331.2006.01071.x","volume":"13","author":"S Shafqat","year":"2006","unstructured":"Shafqat, S., Khealani, B., Awan, F. & Abedin, S. Guillain\u2013Barr\u00e9 syndrome in Pakistan: similarity of demyelinating and axonal variants. Eur. J. Neurol. 13, 662\u2013665 (2006).","journal-title":"Eur. J. Neurol."},{"key":"467_CR57","first-page":"Doc16","volume":"13","author":"SR Sudulagunta","year":"2015","unstructured":"Sudulagunta, S. R. et al. Guillain\u2013Barr\u00e9 syndrome: clinical profile and management. Ger. Med. Sci. 13, Doc16 (2015).","journal-title":"Ger. Med. Sci."},{"key":"467_CR58","doi-asserted-by":"publisher","first-page":"545","DOI":"10.3329\/jhpn.v28i6.6602","volume":"28","author":"KO Poropatich","year":"2010","unstructured":"Poropatich, K. O., Walker, C. L. F. & Black, R. E. Quantifying the association between Campylobacter infection and Guillain\u2013Barr\u00e9 syndrome: a systematic review. J. Health Popul. Nutr. 28, 545\u2013552 (2010).","journal-title":"J. Health Popul. Nutr."},{"key":"467_CR59","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.1002\/acn3.50946","volume":"6","author":"Y Hao","year":"2019","unstructured":"Hao, Y. et al. Antecedent infections in Guillain\u2013Barr\u00e9 syndrome: a single\u2013center, prospective study. Ann. Clin. Transl. Neurol. 6, 2510\u20132517 (2019).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"467_CR60","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0165-5728(99)00213-1","volume":"100","author":"HJ Willison","year":"1999","unstructured":"Willison, H. J. & O\u2019Hanlon, G. M. The immunopathogenesis of Miller Fisher syndrome. J. Neuroimmunol. 100, 3\u201312 (1999).","journal-title":"J. Neuroimmunol."},{"key":"467_CR61","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1128\/JCM.43.1.335-339.2005","volume":"43","author":"M Takahashi","year":"2005","unstructured":"Takahashi, M., Koga, M., Yokoyama, K. & Yuki, N. Epidemiology of Campylobacter jejuni isolated from patients with Guillain\u2013Barr\u00e9 and Miller Fisher syndromes in Japan. J. Clin. Microbiol. 43, 335\u2013339 (2005).","journal-title":"J. Clin. Microbiol."},{"key":"467_CR62","doi-asserted-by":"publisher","first-page":"226","DOI":"10.3201\/eid1802.111126","volume":"18","author":"MG Baker","year":"2012","unstructured":"Baker, M. G. et al. Declining Guillain\u2013Barr\u00e9 syndrome after campylobacteriosis control, New Zealand, 1988\u20132010. Emerg. Infect. Dis. 18, 226\u2013233 (2012).","journal-title":"Emerg. Infect. Dis."},{"key":"467_CR63","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0005869","volume":"11","author":"AR Styczynski","year":"2017","unstructured":"Styczynski, A. R. et al. Increased rates of Guillain\u2013Barr\u00e9 syndrome associated with Zika virus outbreak in the Salvador metropolitan area, Brazil. PLoS Negl. Trop. Dis. 11, e0005869 (2017).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"467_CR64","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/S0163-4453(99)90031-2","volume":"38","author":"M Kanjalkar","year":"1999","unstructured":"Kanjalkar, M., Karnad, D., Narayana, R. & Shah, P. Guillain\u2013Barr\u00e9 syndrome following malaria. J. Infect. 38, 48\u201350 (1999).","journal-title":"J. Infect."},{"key":"467_CR65","first-page":"1212","volume":"84","author":"P Sithinamsuwan","year":"2001","unstructured":"Sithinamsuwan, P., Sinsawaiwong, S. & Limapichart, K. Guillain\u2013Barr\u00e9\u2019s syndrome associated with Plasmodium falciparum malaria: role of plasma exchange. J. Med. Assoc. Thai. 84, 1212\u20131216 (2001).","journal-title":"J. Med. Assoc. Thai."},{"key":"467_CR66","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1136\/pgmj.68.799.376","volume":"68","author":"A Wijesundere","year":"1992","unstructured":"Wijesundere, A. Guillain\u2013Barr\u00e9 syndrome in Plasmodium falciparum malaria. Postgrad. Med. J. 68, 376\u2013377 (1992).","journal-title":"Postgrad. Med. J."},{"key":"467_CR67","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1212\/WNL.41.6.812","volume":"41","author":"CA Thornton","year":"1991","unstructured":"Thornton, C. A., Latif, A. S. & Emmanuel, J. C. Guillain\u2013Barr\u00e9 syndrome associated with human immunodeficiency virus infection in Zimbabwe. Neurology 41, 812 (1991).","journal-title":"Neurology"},{"key":"467_CR68","first-page":"58","volume":"10","author":"P Gupta","year":"2009","unstructured":"Gupta, P., Jain, V., Chatterjee, S. & Agarwal, A. Acute inflammatory motor axonopathy associated with dengue fever. J. Indian Acad. Clin. Med. 10, 58\u201359 (2009).","journal-title":"J. Indian Acad. Clin. Med."},{"key":"467_CR69","doi-asserted-by":"publisher","DOI":"10.1186\/s13104-015-1672-0","volume":"8","author":"DMPUK Ralapanawa","year":"2015","unstructured":"Ralapanawa, D. M. P. U. K., Kularatne, S. A. M. & Jayalath, W. A. T. A. Guillain\u2013Barr\u00e9 syndrome following dengue fever and literature review. BMC Res. Notes 8, 729 (2015).","journal-title":"BMC Res. Notes"},{"key":"467_CR70","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1590\/S0004-282X2004000100025","volume":"62","author":"NQ Santos","year":"2004","unstructured":"Santos, N. Q., Azoubel, A. C. B., Lopes, A. A., Costa, G. & Bacellar, A. Guillain\u2013Barr\u00e9 syndrome in the course of dengue: case report. Arq. Neuropsiquiatr. 62, 144\u2013146 (2004).","journal-title":"Arq. Neuropsiquiatr."},{"key":"467_CR71","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.jocn.2020.04.062","volume":"76","author":"Z Sedaghat","year":"2020","unstructured":"Sedaghat, Z. & Karimi, N. Guillain\u2013Barr\u00e9 syndrome associated with COVID-19 infection: a case report. J. Clin. Neurosci. 76, 233\u2013235 (2020).","journal-title":"J. Clin. Neurosci."},{"key":"467_CR72","doi-asserted-by":"publisher","first-page":"2574","DOI":"10.1056\/NEJMc2009191","volume":"382","author":"G Toscano","year":"2020","unstructured":"Toscano, G. et al. Guillain\u2013Barr\u00e9 syndrome associated with SARS-CoV-2. N. Engl. J. Med. 382, 2574\u20132576 (2020).","journal-title":"N. Engl. J. Med."},{"key":"467_CR73","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S1474-4422(20)30109-5","volume":"19","author":"H Zhao","year":"2020","unstructured":"Zhao, H., Shen, D., Zhou, H., Liu, J. & Chen, S. Guillain\u2013Barr\u00e9 syndrome associated with SARS-CoV-2 infection: causality or coincidence? Lancet Neurol. 19, 383\u2013384 (2020).","journal-title":"Lancet Neurol."},{"key":"467_CR74","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.neurol.2020.04.003","volume":"176","author":"J-P Camdessanche","year":"2020","unstructured":"Camdessanche, J.-P. et al. COVID-19 may induce Guillain\u2013Barr\u00e9 syndrome. Rev. Neurol. 176, 516\u2013518 (2020).","journal-title":"Rev. Neurol."},{"key":"467_CR75","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.ajem.2020.09.029","volume":"39","author":"S Nanda","year":"2020","unstructured":"Nanda, S. et al. Covid-19 associated Guillain\u2013Barr\u00e9 syndrome: contrasting tale of four patients from a tertiary care centre in India. Am. J. Emerg. Med. 39, 125\u2013128 (2020).","journal-title":"Am. J. Emerg. Med."},{"key":"467_CR76","doi-asserted-by":"publisher","unstructured":"Sidig, A., Abbasher, K., Abbasher, H., Abbasher, M. & Hussien, A. COVID-19 and Guillain\u2013Barr\u00e9 syndrome case report. J. Neurol. Neurobiol. 7, https:\/\/doi.org\/10.16966\/2379-7150.169 (2020).","DOI":"10.16966\/2379-7150.169"},{"key":"467_CR77","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.neurol.2020.04.007","volume":"176","author":"H El Otmani","year":"2020","unstructured":"El Otmani, H. et al. Covid-19 and Guillain\u2013Barr\u00e9 syndrome: more than a coincidence! Rev. Neurol. 176, 518\u2013519 (2020).","journal-title":"Rev. Neurol."},{"key":"467_CR78","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awaa433","author":"S Keddie","year":"2020","unstructured":"Keddie, S. et al. Epidemiological and cohort study finds no association between COVID-19 and Guillain\u2013Barr\u00e9 syndrome. Brain https:\/\/doi.org\/10.1093\/brain\/awaa433 (2020).","journal-title":"Brain"},{"issue":"Suppl. 10","key":"467_CR79","doi-asserted-by":"publisher","first-page":"S897","DOI":"10.1093\/infdis\/jix511","volume":"216","author":"LS Mu\u00f1oz","year":"2017","unstructured":"Mu\u00f1oz, L. S., Parra, B., Pardo, C. A. & Neuroviruses Emerging in the Americas Study. Neurological implications of Zika virus infection in adults. J. Infect. Dis. 216 (Suppl. 10), S897\u2013S905 (2017).","journal-title":"J. Infect. Dis."},{"key":"467_CR80","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1136\/jnnp-2020-324491","volume":"91","author":"A Uncini","year":"2020","unstructured":"Uncini, A., Vallat, J.-M. & Jacobs, B. C. Guillain\u2013Barr\u00e9 syndrome in SARS-CoV-2 infection: an instant systematic review of the first six months of pandemic. J. Neurol. Neurosurg. Psychiatry 91, 1105\u20131110 (2020).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"467_CR81","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-020-10124-x","author":"S Abu-Rumeileh","year":"2020","unstructured":"Abu-Rumeileh, S., Abdelhak, A., Foschi, M., Tumani, H. & Otto, M. Guillain\u2013Barr\u00e9 syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases. J. Neurol. https:\/\/doi.org\/10.1007\/s00415-020-10124-x (2020).","journal-title":"J. Neurol."},{"key":"467_CR82","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/jns5.12074","volume":"19","author":"S Blum","year":"2014","unstructured":"Blum, S. & McCombe, P. A. Genetics of Guillain\u2013Barr\u00e9 syndrome (GBS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): current knowledge and future directions. J. Peripher. Nerv. Syst. 19, 88\u2013103 (2014).","journal-title":"J. Peripher. Nerv. Syst."},{"key":"467_CR83","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jneuroim.2006.05.018","volume":"177","author":"CM Caporale","year":"2006","unstructured":"Caporale, C. M. et al. Susceptibility to Guillain\u2013Barr\u00e9 syndrome is associated to polymorphisms of CD1 genes. J. Neuroimmunol. 177, 112\u2013118 (2006).","journal-title":"J. Neuroimmunol."},{"key":"467_CR84","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0192703","volume":"13","author":"Z Islam","year":"2018","unstructured":"Islam, Z. et al. FAS promoter polymorphisms and serum sFas level are associated with increased risk of nerve damage in Bangladeshi patients with Guillain\u2013Barr\u00e9 syndrome. PLoS ONE 13, e0192703 (2018).","journal-title":"PLoS ONE"},{"key":"467_CR85","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1177\/026010609601000401","volume":"10","author":"LS Harbige","year":"1996","unstructured":"Harbige, L. S. Nutrition and immunity with emphasis on infection and autoimmune disease. Nutr. Health 10, 285\u2013312 (1996).","journal-title":"Nutr. Health"},{"key":"467_CR86","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ensci.2019.02.001","volume":"14","author":"S D\u00edaz-Soto","year":"2019","unstructured":"D\u00edaz-Soto, S., Chavez, K., Chaca, A., Alanya, J. & Tirado-Hurtado, I. Outbreak of Guillain\u2013Barr\u00e9 syndrome in Peru. eNeurologicalSci 14, 89\u201390 (2019).","journal-title":"eNeurologicalSci"},{"key":"467_CR87","doi-asserted-by":"publisher","first-page":"134","DOI":"10.3201\/eid2301.161290","volume":"23","author":"E Dirlikov","year":"2017","unstructured":"Dirlikov, E. et al. Guillain\u2013Barr\u00e9 syndrome and healthcare needs during Zika virus transmission, Puerto Rico, 2016. Emerg. Infect. Dis. 23, 134\u2013136 (2017).","journal-title":"Emerg. Infect. Dis."},{"key":"467_CR88","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-018-1052-4","volume":"16","author":"L Mier-y-Teran-Romero","year":"2018","unstructured":"Mier-y-Teran-Romero, L., Delorey, M. J., Sejvar, J. J. & Johansson, M. A. Guillain\u2013Barr\u00e9 syndrome risk among individuals infected with Zika virus: a multi-country assessment. BMC Med. 16, 67 (2018).","journal-title":"BMC Med."},{"key":"467_CR89","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1038\/nature06536","volume":"451","author":"KE Jones","year":"2008","unstructured":"Jones, K. E. et al. Global trends in emerging infectious diseases. Nature 451, 990\u2013993 (2008).","journal-title":"Nature"},{"key":"467_CR90","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/S1474-4422(20)30232-5","volume":"19","author":"MLB Ferreira","year":"2020","unstructured":"Ferreira, M. L. B. et al. Neurological disease in adults with Zika and chikungunya virus infection in Northeast Brazil: a prospective observational study. Lancet Neurol. 19, 826\u2013839 (2020).","journal-title":"Lancet Neurol."},{"key":"467_CR91","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jcv.2016.01.016","volume":"77","author":"O Simon","year":"2016","unstructured":"Simon, O. et al. Early Guillain\u2013Barr\u00e9 syndrome associated with acute dengue fever. J. Clin. Virol. 77, 29\u201331 (2016).","journal-title":"J. Clin. Virol."},{"key":"467_CR92","doi-asserted-by":"publisher","first-page":"96","DOI":"10.3390\/ijerph15010096","volume":"15","author":"R Lowe","year":"2018","unstructured":"Lowe, R. et al. The Zika virus epidemic in Brazil: from discovery to future implications. Int. J. Environ. Res. Publ. Health 15, 96 (2018).","journal-title":"Int. J. Environ. Res. Publ. Health"},{"key":"467_CR93","first-page":"7812","volume":"34","author":"Y Zhang","year":"2004","unstructured":"Zhang, Y. et al. Epidemiological survey of the incidence of Guillain\u2013Barr\u00e9 syndrome in Harbin from 1997 to 1999. Chin. J. Clin. Rehab. 34, 7812\u20137815 (2004).","journal-title":"Chin. J. Clin. Rehab."},{"key":"467_CR94","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1136\/jnnp-2020-324230","volume":"91","author":"SE Leonhard","year":"2020","unstructured":"Leonhard, S. E., Cornblath, D. R., Endtz, H. P., Sejvar, J. J. & Jacobs, B. C. Guillain\u2013Barr\u00e9 syndrome in times of pandemics. J. Neurol. Neurosurg. Psychiatry 91, 1027\u20131029 (2020).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"467_CR95","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.1002\/ana.410270707","volume":"27","author":"AK Asbury","year":"1990","unstructured":"Asbury, A. K. & Cornblath, D. R. Assessment of current diagnostic criteria for Guillain\u2013Barr\u00e9 syndrome. Ann. Neurol. 27, S21\u2013S24 (1990).","journal-title":"Ann. Neurol."},{"key":"467_CR96","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1111\/jns.12189","volume":"21","author":"MB Islam","year":"2016","unstructured":"Islam, M. B. et al. Guillain\u2013Barr\u00e9 syndrome in Bangladesh: validation of Brighton criteria. J. Peripher. Nerv. Syst. 21, 345\u2013351 (2016).","journal-title":"J. Peripher. Nerv. Syst."},{"key":"467_CR97","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/j.1529-8027.2012.00433.x","volume":"17","author":"HC Lehmann","year":"2012","unstructured":"Lehmann, H. C., Hughes, R. A., Kieseier, B. C. & Hartung, H. P. Recent developments and future directions in Guillain\u2013Barr\u00e9 syndrome. J. Peripher. Nerv. Syst. 17, 57\u201370 (2012).","journal-title":"J. Peripher. Nerv. Syst."},{"key":"467_CR98","doi-asserted-by":"publisher","first-page":"9697","DOI":"10.1016\/j.vaccine.2011.09.123","volume":"29","author":"FJ Mateen","year":"2011","unstructured":"Mateen, F. J. et al. Guillain\u2013Barr\u00e9 syndrome in India: population-based validation of the Brighton criteria. Vaccine 29, 9697\u20139701 (2011).","journal-title":"Vaccine"},{"key":"467_CR99","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1159\/000503101","volume":"81","author":"Y Zeng","year":"2019","unstructured":"Zeng, Y. et al. Clinical features and the validation of the Brighton criteria in Guillain\u2013Barr\u00e9 syndrome: retrospective analysis of 72 hospitalized patients in three years. Eur. Neurol. 81, 231\u2013238 (2019).","journal-title":"Eur. Neurol."},{"key":"467_CR100","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00415-011-6330-4","volume":"259","author":"N Yuki","year":"2012","unstructured":"Yuki, N. et al. Guillain\u2013Barr\u00e9 syndrome associated with normal or exaggerated tendon reflexes. J. Neurol. 259, 1181\u20131190 (2012).","journal-title":"J. Neurol."},{"key":"467_CR101","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1212\/WNL.51.4.1110","volume":"51","author":"B Jacobs","year":"1998","unstructured":"Jacobs, B. et al. The spectrum of antecedent infections in Guillain\u2013Barr\u00e9 syndrome: a case\u2013control study. Neurology 51, 1110\u20131115 (1998).","journal-title":"Neurology"},{"key":"467_CR102","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1212\/WNL.0b013e31820e7b62","volume":"76","author":"J Roodbol","year":"2011","unstructured":"Roodbol, J. et al. Recognizing Guillain\u2013Barr\u00e9 syndrome in preschool children. Neurology 76, 807\u2013810 (2011).","journal-title":"Neurology"},{"key":"467_CR103","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1055\/s-2007-981686","volume":"38","author":"R Korinthenberg","year":"2007","unstructured":"Korinthenberg, R., Schessl, J. & Kirschner, J. Clinical presentation and course of childhood Guillain\u2013Barr\u00e9 syndrome: a prospective multicentre study. Neuropediatrics 38, 10\u201317 (2007).","journal-title":"Neuropediatrics"},{"key":"467_CR104","first-page":"607","volume":"47","author":"F Khan","year":"2011","unstructured":"Khan, F., Ng, L., Amatya, B., Brand, C. & Turner-Stokes, L. Multidisciplinary care for Guillain\u2013Barr\u00e9 syndrome. Eur. J. Phys. Rehabil. Med. 47, 607\u2013612 (2011).","journal-title":"Eur. J. Phys. Rehabil. Med."},{"key":"467_CR105","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1136\/jnnp-2016-314862","volume":"88","author":"C Verboon","year":"2017","unstructured":"Verboon, C., van Doorn, P. A. & Jacobs, B. C. Treatment dilemmas in Guillain\u2013Barr\u00e9 syndrome. J. Neurol. Neurosurg. Psychiatry 88, 346\u2013352 (2017).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"467_CR106","first-page":"263","volume":"19","author":"JR Chaudhuri","year":"2014","unstructured":"Chaudhuri, J. R. et al. Clinical outcome of Guillain\u2013Barr\u00e9 syndrome with various treatment methods and cost effectiveness: a study from tertiary care center in South India: Yashoda GBS registry. Neurol. Asia 19, 263\u2013270 (2014).","journal-title":"Neurol. Asia"},{"key":"467_CR107","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S0140-6736(17)30055-7","volume":"389","author":"HJ Willison","year":"2017","unstructured":"Willison, H. J., Jacobs, B. C. & van Doorn, P. A. Guillain\u2013Barr\u00e9 syndrome: surveillance and cost of treatment strategies \u2014 authors\u2019 reply. Lancet 389, 253\u2013254 (2017).","journal-title":"Lancet"},{"key":"467_CR108","doi-asserted-by":"publisher","first-page":"732","DOI":"10.3109\/0886022X.2014.890859","volume":"36","author":"CK Kishore","year":"2014","unstructured":"Kishore, C. K. et al. Management of Guillain\u2013Barr\u00e9 syndrome with plasmapheresis or immunoglobulin: our experience from a tertiary care institute in South India. Ren. Fail. 36, 732\u2013736 (2014).","journal-title":"Ren. Fail."},{"key":"467_CR109","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1002\/acn3.706","volume":"6","author":"Z Islam","year":"2019","unstructured":"Islam, Z. et al. Risk factors for respiratory failure in Guillain\u2013Barr\u00e9 syndrome in Bangladesh: a prospective study. Ann. Clin. Transl. Neurol. 6, 324\u2013332 (2019).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"467_CR110","doi-asserted-by":"publisher","first-page":"118","DOI":"10.4103\/0973-6247.187940","volume":"10","author":"RR Iyer","year":"2016","unstructured":"Iyer, R. R., Shah, P. H., Roy, S. S. K. & Suri, S. K. K. Reducing the economic burden in management of Guillain\u2013Barr\u00e9 syndrome using modified plasmapheresis. Asian J. Transfus. Sci. 10, 118\u2013121 (2016).","journal-title":"Asian J. Transfus. Sci."},{"issue":"Suppl. 15","key":"467_CR111","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1212\/WNL.94.15_supplement.763","volume":"94","author":"Z Islam","year":"2020","unstructured":"Islam, Z. et al. Inhibition of C1q, initiator of the classical complement cascade, by ANX005 for the treatment of Guillain\u2013Barr\u00e9 syndrome: results from a phase 1b study [abstract]. Neurology 94 (Suppl. 15), 763 (2020).","journal-title":"Neurology"},{"key":"467_CR112","unstructured":"Lucchini, S. et al. in Economics of AIDS and Access to HIV-AIDS Care in Developing Countries: Issues and Challenges (eds Moatti, J. P. et al.) 169\u2013211 (ANRS, 2003)."},{"key":"467_CR113","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1093\/qjmed\/hcv190","volume":"109","author":"J Kalita","year":"2016","unstructured":"Kalita, J., Ranjan, A. & Misra, U. Outcome of Guillain\u2013Barr\u00e9 syndrome patients with respiratory paralysis. QJM 109, 319\u2013323 (2016).","journal-title":"QJM"},{"key":"467_CR114","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/s41582-019-0250-9","volume":"15","author":"SE Leonhard","year":"2019","unstructured":"Leonhard, S. E. et al. Diagnosis and management of Guillain\u2013Barr\u00e9 syndrome in ten steps. Nat. Rev. Neurol. 15, 671\u2013683 (2019).","journal-title":"Nat. Rev. Neurol."},{"key":"467_CR115","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-015-1123-2","volume":"19","author":"X Wu","year":"2015","unstructured":"Wu, X. et al. Predictors for mechanical ventilation and short-term prognosis in patients with Guillain\u2013Barr\u00e9 syndrome. Crit. Care 19, 407 (2015).","journal-title":"Crit. Care"},{"key":"467_CR116","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/ana.21976","volume":"67","author":"C Walgaard","year":"2010","unstructured":"Walgaard, C. et al. Prediction of respiratory insufficiency in Guillain\u2013Barr\u00e9 syndrome. Ann. Neurol. 67, 781\u2013787 (2010).","journal-title":"Ann. Neurol."},{"key":"467_CR117","unstructured":"Adhikary, T. S. & Mollah, S. ICU facilities scanty at government hospitals of Bangladesh. The Daily Star (Bangladesh) (6 Feb 2021)."},{"key":"467_CR118","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2377-13-95","volume":"13","author":"I Gonz\u00e1lez-Su\u00e1rez","year":"2013","unstructured":"Gonz\u00e1lez-Su\u00e1rez, I., Sanz-Gallego, I., de Rivera, F. J. R. & Arpa, J. Guillain\u2013Barr\u00e9 syndrome: natural history and prognostic factors: a retrospective review of 106 cases. BMC Neurol. 13, 95 (2013).","journal-title":"BMC Neurol."},{"key":"467_CR119","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.ejpn.2010.11.008","volume":"15","author":"EF Halawa","year":"2011","unstructured":"Halawa, E. F., Ahmed, D. & Nada, M. A. Guillain\u2013Barr\u00e9 syndrome as a prominent cause of childhood acute flaccid paralysis in post polio eradication era in Egypt. Eur. J. Paediatr. Neurol. 15, 241\u2013246 (2011).","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"467_CR120","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.3390\/ijerph15102165","volume":"15","author":"T Bright","year":"2018","unstructured":"Bright, T., Wallace, S. & Kuper, H. A systematic review of access to rehabilitation for people with disabilities in low- and middle-income countries. Int. J. Environ. Res. Publ. Health 15, 2165 (2018).","journal-title":"Int. J. Environ. Res. Publ. Health"},{"key":"467_CR121","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1136\/jnnp-2011-301882","volume":"83","author":"YA Rajabally","year":"2012","unstructured":"Rajabally, Y. A. & Uncini, A. Outcome and its predictors in Guillain\u2013Barr\u00e9 syndrome. J. Neurol. Neurosurg. Psychiatry 83, 711\u2013718 (2012).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"467_CR122","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1136\/jnnp.2004.051136","volume":"76","author":"A Hiraga","year":"2005","unstructured":"Hiraga, A. et al. Recovery patterns and long term prognosis for axonal Guillain\u2013Barr\u00e9 syndrome. J. Neurol. Neurosurg. Psychiatry 76, 719\u2013722 (2005).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"467_CR123","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1159\/000445347","volume":"75","author":"IS Merkies","year":"2016","unstructured":"Merkies, I. S. & Kieseier, B. C. Fatigue, pain, anxiety and depression in Guillain\u2013Barr\u00e9 syndrome and chronic inflammatory demyelinating polyradiculoneuropathy. Eur. Neurol. 75, 199\u2013206 (2016).","journal-title":"Eur. Neurol."},{"key":"467_CR124","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1007\/s00415-010-5653-x","volume":"257","author":"F Khan","year":"2010","unstructured":"Khan, F., Pallant, J., Ng, L. & Bhasker, A. Factors associated with long-term functional outcomes and psychological sequelae in Guillain\u2013Barr\u00e9 syndrome. J. Neurol. 257, 2024\u20132031 (2010).","journal-title":"J. Neurol."},{"key":"467_CR125","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1212\/WNL.0b013e3182104407","volume":"76","author":"C Walgaard","year":"2011","unstructured":"Walgaard, C. et al. Early recognition of poor prognosis in Guillain\u2013Barr\u00e9 syndrome. Neurology 76, 968\u2013975 (2011).","journal-title":"Neurology"},{"key":"467_CR126","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1111\/ane.12995","volume":"138","author":"ME Dourado J\u00fanior","year":"2018","unstructured":"Dourado J\u00fanior, M. E. et al. EGOS has a reduced capacity to predicts GBS prognosis in Northeast Brazil. Acta Neurol. Scand. 138, 459\u2013462 (2018).","journal-title":"Acta Neurol. Scand."},{"key":"467_CR127","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1111\/jns.12234","volume":"22","author":"Y Yamagishi","year":"2017","unstructured":"Yamagishi, Y. et al. Markers for Guillain\u2013Barr\u00e9 syndrome with poor prognosis: a multi\u2013center study. J. Peripher. Nerv. Syst. 22, 433\u2013439 (2017).","journal-title":"J. Peripher. Nerv. Syst."},{"key":"467_CR128","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/jns.12320","volume":"24","author":"CY Tan","year":"2019","unstructured":"Tan, C. Y., Razali, S. N., Goh, K. J. & Shahrizaila, N. The utility of Guillain\u2013Barr\u00e9 syndrome prognostic models in Malaysian patients. J. Peripher. Nerv. Syst. 24, 168\u2013173 (2019).","journal-title":"J. Peripher. Nerv. Syst."},{"key":"467_CR129","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1136\/jnnp.2005.081547","volume":"77","author":"RC Graham","year":"2006","unstructured":"Graham, R. C. & Hughes, R. A modified peripheral neuropathy scale: the overall neuropathy limitations scale. J. Neurol. Neurosurg. Psychiatry 77, 973\u2013976 (2006).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"467_CR130","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/jns.12119","volume":"20","author":"MP Lunn","year":"2015","unstructured":"Lunn, M. P. & Van den Bergh, P. Y. Outcome measures in neuromuscular disease: is the world still flat? J. Peripher. Nerv. Syst. 20, 255\u2013259 (2015).","journal-title":"J. Peripher. Nerv. Syst."},{"key":"467_CR131","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1529-8027.2009.00238.x","volume":"14","author":"SI Van Nes","year":"2009","unstructured":"Van Nes, S. I. et al. Improving fatigue assessment in immune\u2013mediated neuropathies: the modified Rasch\u2013Built fatigue severity scale. J. Peripher. Nerv. Syst. 14, 268\u2013278 (2009).","journal-title":"J. Peripher. Nerv. Syst."},{"key":"467_CR132","doi-asserted-by":"crossref","first-page":"3867946","DOI":"10.1155\/2019\/3867946","volume":"2019","author":"SK Bhagat","year":"2019","unstructured":"Bhagat, S. K., Sidhant, S., Bhatta, M., Ghimire, A. & Shah, B. Clinical profile, functional outcome, and mortality of Guillain\u2013Barr\u00e9 syndrome: a five-year tertiary care experience from Nepal. Neurol. Res. Int. 2019, 3867946 (2019).","journal-title":"Neurol. Res. Int."},{"key":"467_CR133","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.3346\/jkms.2017.32.7.1154","volume":"32","author":"Y-S Park","year":"2017","unstructured":"Park, Y.-S., Lee, K.-J., Kim, S. W., Kim, K. M. & Suh, B. C. Clinical features of post-vaccination Guillain\u2013Barr\u00e9 syndrome (GBS) in Korea. J. Korean Med. Sci. 32, 1154\u20131159 (2017).","journal-title":"J. Korean Med. Sci."}],"container-title":["Nature Reviews Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41582-021-00467-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41582-021-00467-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41582-021-00467-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T22:28:21Z","timestamp":1733956101000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41582-021-00467-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,1]]},"references-count":133,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["467"],"URL":"https:\/\/doi.org\/10.1038\/s41582-021-00467-y","relation":{},"ISSN":["1759-4758","1759-4766"],"issn-type":[{"value":"1759-4758","type":"print"},{"value":"1759-4766","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,1]]},"assertion":[{"value":"1 February 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}